H
Hirohito Metoki
Researcher at Tohoku Pharmaceutical University
Publications - 326
Citations - 12676
Hirohito Metoki is an academic researcher from Tohoku Pharmaceutical University. The author has contributed to research in topics: Blood pressure & Population. The author has an hindex of 47, co-authored 276 publications receiving 10877 citations. Previous affiliations of Hirohito Metoki include Japan Society for the Promotion of Science & Tohoku University.
Papers
More filters
Journal ArticleDOI
Blood pressure changes during pregnancy.
Mami Ishikuro,Taku Obara,Hirohito Metoki,Takayoshi Ohkubo,Takayoshi Ohkubo,Nobuo Yaegashi,Shinichi Kuriyama,Yutaka Imai +7 more
TL;DR: The study showed that there was less risk ofPIH occurring among pregnant women with low BP at 20 weeks of pregnancy even when these women were found to have high BP at 16 weeks, which might indicate that a decreasing BP in the second trimester (mid-pregnancy fall) has an impact on the occurrence of PIH.
Journal ArticleDOI
Maternal Baseline Characteristics and Perinatal Outcomes: the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study.
Junichi Sugawara,Mami Ishikuro,Taku Obara,Tomomi Onuma,Keiko Murakami,Masahiro Kikuya,Masahiro Kikuya,Fumihiko Ueno,Aoi Noda,Satoshi Mizuno,Tomoko Kobayashi,Yohei Hamanaka,Kichiya Suzuki,Eiichi Kodama,Naho Tsuchiya,Akira Uruno,Yoichi Suzuki,Osamu Tanabe,Osamu Tanabe,Hideyasu Kiyomoto,Akito Tsuboi,Atsushi Shimizu,Atsushi Shimizu,Seizo Koshiba,Naoko Minegishi,Soichi Ogishima,Gen Tamiya,Hirohito Metoki,Atsushi Hozawa,Nobuo Fuse,Kengo Kinoshita,Shigeo Kure,Nobuo Yaegashi,Shinichi Kuriyama,Masayuki Yamamoto +34 more
TL;DR: Young maternal participants had a tendency toward a higher incidence of threatened abortion and threatened premature labor, while older age groups exhibited a significantly higher rate of low lying placenta, placentA previa, gestational diabetes, and hypertensive disorders of pregnancy.
Journal ArticleDOI
Maternity Log study: a longitudinal lifelog monitoring and multiomics analysis for the early prediction of complicated pregnancy.
Junichi Sugawara,Daisuke Ochi,Daisuke Ochi,Riu Yamashita,Takafumi Yamauchi,Takafumi Yamauchi,Daisuke Saigusa,Maiko Wagata,Taku Obara,Mami Ishikuro,Tsunemoto Yoshiki,yuki harada,Tomoko Shibata,Takahiro Mimori,Junko Kawashima,Fumiki Katsuoka,Takako Igarashi-Takai,Soichi Ogishima,Hirohito Metoki,Hiroaki Hashizume,Nobuo Fuse,Naoko Minegishi,Seizo Koshiba,Osamu Tanabe,Osamu Tanabe,Shinichi Kuriyama,Kengo Kinoshita,Shigeo Kure,Nobuo Yaegashi,Masayuki Yamamoto,Satoshi Hiyama,Satoshi Hiyama,Masao Nagasaki +32 more
TL;DR: The Maternity Log study was designed to construct a time-course high-resolution reference catalogue of bioinformatic data in pregnancy and explore the associations between genomic and environmental factors and the onset of pregnancy complications, using continuous lifestyle monitoring combined with multiomics data on the genome, transcriptome, proteome, metabolome and microbiome.
Journal ArticleDOI
Progress report on the HOMED-BP Study: hypertension objective treatment based on measurement by electrical devices of blood pressure study.
Yohei Aoki,Kei Asayama,Takayoshi Ohkubo,Takuya Nishimura,Masahiro Kikuya,Hirohito Metoki,Atsushi Hozawa,Junichiro Hashimoto,Mari Michimata,Mitsunobu Matsubara,Tsutomu Araki,Yutaka Imai +11 more
TL;DR: This first large‐scale intervention trial in Japan using a Prospective Randomized Open Blinded Endpoint (PROBE) design to determine an optimal target blood pressure (BP) level on the basis of self‐measured BP at home, and an optimal initial course of antihypertensive medication.
Journal ArticleDOI
Pharmacists' awareness and attitude toward blood pressure measurement at home and in the pharmacy in Japan.
Taku Obara,Takayoshi Ohkubo,Koji Tanaka,Michihiro Satoh,Kazuki Ishikura,Mitsuru Kobayashi,Hirohito Metoki,Kei Asayama,Masahiro Kikuya,Yuriko Murai,Nariyasu Mano,Sentaro Oide,Yutaka Imai +12 more
TL;DR: Investigation of Japanese pharmacists' awareness and attitude toward blood pressure measurement at home (HBP) and in the pharmacy finds that more aggressive promotion of HBP measurement among pharmacists is warranted.